Piper Jaffray Reiterates Neutral, $31 PT on CONMED - Conmed (NYSE:CNMD)

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.

Piper Jaffray maintains its Neutral rating and $31 price target on CONMED Corp. (NASDAQ: CNMD) as top-line growth for the company is driven by new product launches. Piper Jaffray says, “The company has had a number of successful launches this year that have a positive impact on top-line growth, such as Sequent and continued growth in SRS. Management plans to continue this trend through additional product launches in 2H12 to drive the overall sales growth into the mid-to-upper single digits.”CNMD closed at $26.29 per share on Wednesday.

27% profit every 20 days?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!